Objective. To evaluate telomere length (TL) between patients with SLE and healthy controls and to test if TL is associated with carotid plaque.
Introduction
Premature atherosclerotic cardiovascular disease (CVD) has been recognized as a major cause of morbidity and mortality in patients with SLE, an autoimmune disease primarily affecting young women [1, 2] . Since the first report of premature coronary heart disease in lupus patients [3] , an increased rate of myocardial infarction (MI) has been confirmed, especially in young females, where the risk may be 50-fold higher than in the general population [4] . Also, subclinical CVD, evaluated by the presence of carotid artery plaque or coronary artery calcifications, is detected in 3040% of lupus patients vs 916% of age-matched controls [5, 6] .
Telomeres are specialized structures composed of nucleotides that are located at the ends of eukaryotic chromosomes. They cap the termination of double strands of DNA and thus preserve the integrity and stability of the genome during duplication [7] . They can be an indicator of biological ageing since they determine the replication capacity of a cell [8] . Inflammation, oxidative stress and increased cell replication are major environmental factors associated with accelerated shortening of telomeres [9] . Telomere shortening has been noted in the peripheral white blood cells of patients with CVD; it has been associated with increased carotid intimamedial thickness (IMT) and atherosclerotic plaque in the general population [1015] . Since inflammation represents a major pathophysiological mechanism in CVD [16] , it is plausible to test whether the phenomenon of telomere shortening is increased in patients with SLE, a disease with underlying chronic inflammation that can be present from a young age and be ongoing for many years. A recent study in young adolescents noted a significant and inverse association between leucocyte telomere length (TL) and inflammatory markers including CRP and fibrinogen and these associations were not affected by multiple adjustments for behavioural and metabolic factors [17] . Results from studies in patients with SLE have also shown that TL is shortened in both mononuclear and polymorphonuclear (PMN) cells compared with control patients. In addition, PMN premature telomere shortening was more prominent in SLE patients younger than 45 years and was associated with disease activity [18] . The aims of this study were to compare TL between patients with SLE and healthy controls and to test whether shortening TL is associated with premature subclinical CVD as measured by the presence of carotid plaque in order to assess the potential usefulness of TL as a novel biomarker for cardiovascular risk in patients with SLE.
Methods

Study participants
We studied 154 patients with SLE and 152 healthy subjects who participated in the parent study SOLVABLE (Study of Lupus Vascular and Bone Long-Term Endpoints). The protocol for SOLVABLE, which included permission to use genetic material collected as part of SOLVABLE was approved by the institutional review board at Northwestern University. Study participants provided informed consent prior to enrolment in SOLVABLE according to the Declaration of Helsinki. Only patients who provided permission to perform genetics studies as part of their original SOLVABLE consent were included in the telomere study. Since June 2002, a cohort of women with lupus aged 18 years or older has been followed to examine the effects of lupus on blood vessel and bone complications in SLE in SOLVABLE. Controls from the general population were healthy women matched to patients with SLE by age (±5 years), ethnicity and zip code of residence. Between June 2002 and August 2009, all patients and controls from SOLVABLE participated in the TL pilot study.
Data collection
Data for this analysis were collected at the baseline visit from SOLVABLE. All study subjects had a standardized medical history, physical examination including vital [22] , including serum complement (C3 and C4) and anti-DNA antibody (Crithidia luciliae), was obtained in the patients with SLE. In addition, irreversible damage accrual was measured using the Systemic Lupus International Collaborating Clinics/ACR Damage Index (ACR/SLICC-DI) [23] ; CVD items were omitted from the reported ACR/SLICC-DI score.
Carotid ultrasonography
Carotid US was completed in a single centre. Ultrasonographic measurements were performed using a Siemens Sequioa model C256 equipped with an 8L5 transducer. Sonographers scanned the right and left common carotid artery, carotid bulb and the first 1.5 cm of the internal and external carotid arteries. For each location, the sonographer imaged the vessel in multiple planes. The sonographers scored the US images for plaque in the distal common, carotid bulb and internal arteries. Plaque was defined as a distinct area protruding into the vessel lumen with at least 50% greater thickness than that found in surrounding areas. The reproducibility of the plaque was assessed in five women who underwent two US examinations within 1 week. Each time, the scanning was performed by a different sonographer, and each scan was scored by two readers. Sonographers and readers were trained as part of the reproducibility protocol study in the carotid duplex scan [24] .
Measurement of TL
Genomic DNA was isolated from whole peripheral blood from each patient using the QIAamp DNA Blood Mini Kit (QIAGEN Inc., Valencia, CA, USA). The TL was measured by real-time quantitative PCR analysis according to methods described by Cawthon [25] . Briefly, PCRs (20 ml) were employed with 20 ng of DNA, 12 ml of SYBR GreenER qPCR SuperMix Universal (Invitrogen) and 200 nM of each sense and antisense telomere primers [25, 26] . The telomere PCRs were performed at 95 C for 15 min, followed by 40 cycles at 95 C for 5 s, 56 C for 10 s and 72 C for 60 s. The human b-globin gene was applied as a single-copy gene control, employing 300 and 700 nM sense and primers [25] . The human b-globin PCRs were run separately at 95 C for 5 min, followed by 40 cycles at 95 C for 15 s, 58 C for 1 s and 72 C for 30 s. All PCRs were performed in duplicate using the 7500 Real Time PCR System (Applied Biosystems, Foster City, CA, USA). TL was quantified according to the method described by Cawthon [25] . The absolute telomeric sequence in kilobases (kb) was calculated according to the method described by O'Callaghan et al. [26] with modifications. The molecular weight for the 120 bp doublestranded human b-globin oligonucleotides in our experimental system was employed in the formula for the calculation of the kilobase value for each sample.
Statistical analyses
Characteristics of study patients were summarized in terms of mean and S.D. or count and percentage. Characteristics of cases and controls were compared using Student's t-test or MannWhitney U test for continuous variables and 2 or Fisher's exact test for categorical variables. Multiple logistic regression models were run to identify the risk factors associated with carotid plaque (yes vs no). All analyses were performed using SAS software version 9.2 (SAS, Cary, NC, USA).
Results
One hundred and fifty-four patients with SLE and 152 controls were evaluated and descriptive data from all of the participants are shown in Table 1 . Patients with SLE were younger than controls (43 ± 11 vs 46 ± 10 years, P = 0.008). Both SLE women and controls were predominantly Caucasian (61% vs 70%) followed by African American (26% vs 22%), Hispanic (7% vs 5%) and Asian (6% vs 3%), respectively. BMI and waist:hip ratio measurements and postmenopausal status were similar between the groups. Women with SLE had more cardiovascular events at baseline than controls (6% vs 1%), and this excess was due to cerebrovascular events. Women with SLE had a higher frequency of self-reported hypertension and diabetes mellitus and greater levels of fibrinogen and homocysteine (P < 0.05). However, controls had higher levels of total cholesterol, LDL cholesterol, HDL cholesterol and fasting glucose (P < 0.05). Triglycerides, Lp(a), hs-CRP, glomerular filtration rate (GFR) and 25-OH vitamin D levels were not different between the groups. Women with SLE used aspirin and hypertensive medications more frequently than controls [18% vs 7% and 48% vs 16%, respectively (P < 0.05)]. Anti-hypertensives in SLE women were also used in part to treat renal disease (Table 1) .
At baseline visit, the mean disease duration of women with SLE was 12.2 years, mean disease activity SLEDAI-2K score was 4.1, mean disease damage ACR/SLICC-DI score was 1.73 and 89% had been on corticosteroids, 73% on HCQ and 35% on immunosuppressant at any time during their disease course.
TL in SLE patients and controls
In comparison with healthy controls, patients with SLE had significantly shorter telomeres in their whole peripheral white blood cells (4.57 vs 5.44 kb, P = 0.03), which was observed despite the older mean age in the control group. Age-stratified analysis showed that patients with SLE had shorter TL at a younger age (Table 2) 
TL and carotid plaque
Fifty-eight patients with SLE and 60 controls were identified with carotid plaque (38% vs 39%, P = 0.75). When TL quantification was stratified by age group and by the presence/absence of carotid plaque in patients with SLE and controls, shorter TL at a younger age was observed among patients with SLE (Table 3 ). This observation was statistically significant for women with SLE with carotid plaque compared with controls with carotid plaque for the 35-to 44-year age group (3.58 vs 6.05 kb, P = 0.025) (Fig. 1 ). Among patients with SLE, only age and postmenopausal status were associated with plaque (Table 4) .
Risk factors for carotid plaque
The bivariate associations between risk factors and the presence of carotid plaque showed the following odds ratios (ORs) and 95% CIs: TL, OR = 1.05 (95% CI 0.97, 1.13); age, OR = 1.09 (95% CI 1.06, 1.12); case versus control status, OR = 1.17 (95% CI 0.69, 1.99). In the multiple linear regression model, only older age was a significant risk factor for carotid plaque [OR = 1.08 (95% CI 1.04, 1.11)]. This result was confirmed by several models (see Supplementary Tables 1 and 2 , available at Rheumatology Online).
Discussion
Our study is the first to assess an association between preclinical atherosclerosis as measured by the presence of carotid plaque and TL in patients with SLE. Patients with SLE had shorter TL compared with healthy controls. Since TL shortens with age, the older age in the control group strengthens any observed differences in TL between groups. This observation is further supported by the analysis by age where younger patients with SLE had shorter TL than controls. In our study, the prevalence of carotid plaque in the control group was higher than reported in previous studies [5, 6] . Even though the frequency of carotid plaque was similar between cases and controls, patients with SLE and plaque showed a trend towards shorter TLs at a younger age compared with controls.
www.rheumatology.oxfordjournals.org TL in women from the general population was measured in white blood cells of 1122 women ages 1872 years by Valdes et al. [27] . They found that TL decreased steadily with age at a mean rate of 27 bp/year and this effect is increased due to smoking and obesity, which are risk factors associated with increased oxidative stress and inflammation. Additional studies examining TL and CVD in the general population have been inconclusive in documenting a consistent association between telomere shortening and the initiation and/or progression of CVD [1015] . Results from the Asklepios study in preclinical atherosclerosis showed that the TL of peripheral blood leucocytes was not a significant independent determinant of IMT or plaque presence in either artery (carotid or femoral) or either sex. However, in women but not in men, TL was a weak determinant of combined (carotid or femoral) plaque presence. This study evaluated 2509 volunteers free from established CVD, ages approximately 3566 years, similar to our study sample. They concluded that, although women had shorter TL associated with combined atherosclerotic plaque (carotid or femoral), there is no clear association between shorter systemic telomere and preclinical atherosclerosis, at least as reflected in the carotid and femoral arteries [28] . The studies of Brouilette et al.
[10] and Samani et al. [11] showed that patients with CVD or early MI had shorter TLs compared with control subjects of the same age and sex. On the other hand, the study of Willeit et al. [14] conducted within the scope of a prospective population-based study in 800 subjects ages 4584 years showed that the TL and CVD association should be modified by gender and age because TL was shorter in men than in women and inversely correlated with age. Their results also indicate a differential role of telomere shortening in the various stages of atherosclerosis, with preferential involvement in advanced vessel pathology and acute vascular syndromes.
Patients with SLE are exposed to chronic inflammation for many years [29] and they have premature atherosclerosis compared with age-matched healthy women [36] . We have confirmed the observation of shortened TL in patients with SLE compared with controls and that the shorter TL in peripheral blood mononuclear cells is more predominant in younger patients with SLE than in the controls [3032] . Our findings extend these observations with data to support a possible association between shorter TL and carotid plaque in younger patients with SLE. We acknowledge several limitations of our study. We did not study telomerase activity, so we were not able to study whether the mechanism of telomere maintenance was a contributing factor to telomere shortening. Since this is a pilot study, the sample size was restricted, and larger studies with younger patients are needed to confirm these results. It is also possible that telomere shortening may be associated with premature atherosclerosis in vascular beds other than the carotid, which was the only vascular site analysed for this pilot study. Finally, we utilized carotid plaque as the chosen preclinical atherosclerosis marker to measure in this study. Although there are several other tomography and US markers used to assess preclinical atherosclerosis, evidence suggests that total plaque area is most strongly predictive of cardiovascular risk when compared with carotid IMT [33] . Pulse wave analysis, pulse wave velocity and flow-mediated dilatation can be used to assess vascular stiffness in research and clinical settings. Results from these techniques suggest that variability occurs between measurements and these techniques can be influenced by factors that may confound data [34] . In our study, trained readers scored the US images for plaque in the proximal common, distal common, carotid bulb and internal and external carotid arteries. The grades were summed across the right and left carotid arteries to create an overall measure of the extent of focal plaque.
In conclusion, we have shown that patients with SLE compared with controls have shorter TL in peripheral blood and that this difference is most pronounced in younger women with SLE compared with controls. In addition, we also showed that younger patients with SLE had shorter TL than controls in those with carotid plaque but not those without plaque. However, age was the only independent risk factor associated with carotid plaque status. Studies with a larger sample of SLE patients are needed to confirm these data and determine whether TL is a candidate novel biomarker for CVD in SLE.
Rheumatology key messages
. Women with SLE had significantly shorter TL than healthy women. . Women with SLE trended towards shorter TL at a younger age. . In women with SLE, only older age but not shorter TL was independently associated with the presence of carotid plaque.
